Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of omeprazole on angiogenic markers in preeclampsia
2018-000283-28Phase 4Active
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of omeprazole in preeclampsia (2 arms). Primary endpoint: Primary endpoint: change in sFlt-1 levels. Started May 2018; status: active.
02
Drugs
omeprazole
03
Conditions
preeclampsia
Beyond the preview
Go deeper on 2018-000283-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000283-28.